Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Bulletin Du Cancer
|
March 29, 2025
[Update on marginal zone lymphoma classification, diagnosis and treatment in 2024]
Lucie Oberic, Krimo Bouabdallah, Sylvain Carras, et al.
Kidney360
|
January 31, 2025
Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate
Stanislas Faguer, Chloé Medrano, Suzanne Tavitian, et al.
BMC Cancer
|
December 5, 2019
Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey
Gisèle Compaci, Cécile Conte, Lucie Oberic, et al.
Clinical Case Reports
|
March 5, 2020
Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Guillaume Beziat, Martin Gauthier, Caroline Protin, et al.
European Journal of Haematology
|
June 19, 2014
Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients
Lucie Oberic, Willy Vaillant, Benjamin Hebraud, et al.
BMC Cancer
|
October 27, 2015
Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy
Gisèle Compaci, Manuela Rueter, Sébastien Lamy, et al.
Gynecologic Oncology Reports
|
September 30, 2020
Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report
Mathilde Del, Martina Aida Angeles, Charlotte Syrykh, et al.
Therapeutic Drug Monitoring
|
September 14, 2020
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients
Fanny Gallais, Lucie Oberic, Stanislas Faguer, et al.
Annals of Hematology
|
February 20, 2019
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia
Loic Ysebaert, Marie Larcher, Gisele Compaci, et al.
Journal of Geriatric Oncology
|
September 28, 2013
First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
Anne-Sophie Michallet, Bruno Cazin, Emmanuel Bouvet, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Bulletin Du Cancer
|
March 29, 2025
[Update on marginal zone lymphoma classification, diagnosis and treatment in 2024]
Lucie Oberic, Krimo Bouabdallah, Sylvain Carras, et al.
Kidney360
|
January 31, 2025
Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate
Stanislas Faguer, Chloé Medrano, Suzanne Tavitian, et al.
BMC Cancer
|
December 5, 2019
Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey
Gisèle Compaci, Cécile Conte, Lucie Oberic, et al.
Clinical Case Reports
|
March 5, 2020
Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Guillaume Beziat, Martin Gauthier, Caroline Protin, et al.
European Journal of Haematology
|
June 19, 2014
Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients
Lucie Oberic, Willy Vaillant, Benjamin Hebraud, et al.
BMC Cancer
|
October 27, 2015
Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy
Gisèle Compaci, Manuela Rueter, Sébastien Lamy, et al.
Gynecologic Oncology Reports
|
September 30, 2020
Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report
Mathilde Del, Martina Aida Angeles, Charlotte Syrykh, et al.
Therapeutic Drug Monitoring
|
September 14, 2020
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients
Fanny Gallais, Lucie Oberic, Stanislas Faguer, et al.
Annals of Hematology
|
February 20, 2019
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia
Loic Ysebaert, Marie Larcher, Gisele Compaci, et al.
Journal of Geriatric Oncology
|
September 28, 2013
First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
Anne-Sophie Michallet, Bruno Cazin, Emmanuel Bouvet, et al.
Page
of 7